top of page

Black Diamond Therapeutics' CEO on the company's 'MasterKey' approach to precision oncology

Mark Velleca describes Black Diamond's 'MasterKey' approach to precision oncology that's aimed at solving many mutations at once, and updates us on lead programs targeting EGFR and BRAF.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

SAV_Logo_2024.png

At Savills, the Life Sciences Team specializes in helping biotech companies unlock their full potential by aligning real estate strategies with their scientific and business goals. As a leading global commercial real estate advisory firm, we focus exclusively on occupier services and tenant representation, acting as a trusted partner to some of the most innovative companies in the industry.

bottom of page